Indication
Acute Respiratory Distress Syndrome Due to Disease Caused by SARS-CoV-2
1 clinical trial
2 products
Clinical trial
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19Status: Completed, Estimated PCD: 2023-05-31
Product
SivelestatProduct
Control